Acerca de Stichting Koningin Wilhelmina Fonds voor de Nederlandse Kankerbestrijding
KWF is the Netherlands’ leading cancer charity and research funder, supporting the full continuum from prevention and early detection to treatment, implementation, and life after cancer. Its grantmaking is strongly science-driven and nationally focused, with a clear emphasis on turning oncology research into patient-relevant practice through clinical translation, implementation, and shared research infrastructure. It tends to fund Dutch universities, UMCs, cancer institutes, research consortia, and early-career investigators rather than broad community nonprofits.
Áreas de Enfoque
Cancer ResearchClinical Translation in OncologyImplementation Science in Cancer CareEarly-Career Cancer ResearchersHigh-Risk Exploratory Oncology ResearchCancer Research Infrastructure and Shared Platforms
Enfoque de Donación
Competitive, program-based grantmaking with indicative budgets rather than open-ended awards. Grants are typically multi-year and can be substantial (often several hundred thousand euros), with separate calls for project research, implementation, young investigators, high-risk pilot work, consortia, and infrastructure; some programs are explicitly geared to national-scale adoption in the Netherlands.
¿Quieres un Pitch Personalizado para Stichting Koningin Wilhelmina Fonds voor de Nederlandse Kankerbestrijding?
Regístrate gratis para ver qué tan bien se adapta tu organización sin fines de lucro a este financiador, obtener un pitch generado por IA y descubrir fundaciones similares.
Inteligencia semanal sobre subvenciones para líderes de impacto social. Oportunidades seleccionadas, tendencias de financiamiento e ideas estratégicas — gratis.
Únete a más de 500 líderes de impacto social. Cancela tu suscripción cuando quieras. Política de privacidad
De confianza para equipos con misión social en organizaciones de todo el país
Cómo acercarte a este financiador
Monitor KWF’s program-specific calls and apply through the relevant research or implementation track; eligibility is generally limited to Dutch-based institutions and collaborations. Tailor proposals to patient-relevant outcomes, demonstrate added value for oncology practice, and for implementation or consortium grants show readiness for national uptake, strong collaboration, and clear budget justification.
Beneficiarios destacados:
• LUMC
• Amsterdam UMC
• Oncode Institute
• Antoni van Leeuwenhoek / Nederlands Kanker Instituut
• kanker.nl
Oportunidades de Subvenciones Abiertas
Financiamiento actual y próximo de Stichting Koningin Wilhelmina Fonds voor de Nederlandse Kankerbestrijding al que tu organización sin fines de lucro podría postularse.
Abierta ahoraCierra el 1 sept 2026
Exploration Call
basic researchcredentialingcancer biology+5 más
¿Quién puede postularse? Project proposals must fit the Basic Research or Credentialing phases; proposals spanning multiple phases must choose the phase that best reflects the central focus. Young Investigator Grant applications are handled in a separate call.
Fecha límite: Call 2026-3 / EXPL: pre-proposals close 31 March 2026; full proposals close 1 September 2026. Call 2026-1 / EXPL: pre-proposals closed 11 November 2025; full proposals closed 7 April 2026.
implementation researchclinical practice adoptionhealth services research+3 más
¿Quién puede postularse? Projects must have a research focus and fit within regular funding types such as Research Project, Young Investigator Grant, or Unique High-Risk Project.
Fecha límite: No separate deadline; applications follow the relevant regular KWF call deadlines.
high-risk researchpilot studiesnovel hypotheses+1 más
¿Quién puede postularse? Project leader must hold a PhD and be employed by a Dutch institute; project leader should have sufficient experience in the specific scientific area; duration is typically 1 to 1.5 years; main execution in the Netherlands.
Fecha límite: Can be submitted within the Exploration and Development calls; current relevant windows are 2026-3 Exploration and 2026-2 Development, plus future 2027 calls.
cancer researchtranslational researchbasic research+2 más
¿Quién puede postularse? Project leader must hold a PhD and be employed by a Dutch institute during the project; at least one scientific researcher working 0.5 FTE per year is required; typical duration is 4 years; main focus must be in the Netherlands.
Fecha límite: Available through Exploration and Development calls depending on research phase; current windows follow those calls.
collaborative researchtranslational cancer researchcomplex research questions
¿Quién puede postularse? Project must be hypothesis-driven with defined duration and final analyses; project leader must hold a PhD; at least one scientific researcher at 0.5 FTE per year; a project manager is required; collaboration agreement signed by lead institute and all participating organizations is required before starting.
Fecha límite: Available through Exploration and Development calls depending on research phase; current windows follow those calls.
creation of modalitypreclinical researchclinical research+2 más
¿Quién puede postularse? Project proposals must fall within Creation of Modality, Preclinical, Clinical, or Implementation research phases. Young Investigator Grant applications are handled in a separate call.
Fecha límite: Call 2026-2 / DEV: pre-proposals close 11 November 2025; full proposals close 31 March 2026. Call 2027-DEV: pre-proposals close 6 October 2026; full proposals close 16 March 2027.
Las fechas límite y los requisitos de elegibilidad son un resumen de fuentes públicas y pueden cambiar — confirma siempre los detalles en la página oficial de solicitud del financiador antes de postularte.